Aldevron News

Supporting AAV and Lentiviral vector development and commercialization

pharmas almanac-thumbAldevron's James Brown is a featured author in the second quarter edition of Pharma's Almanac, a magazine covering the industry's most intensive markets, active business sectors and major players.

Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron is supporting the innovation of drug developers in this space by providing standardized royalty-free, bulk AAV helper and lentiviral packaging plasmids for research and GMP production.

Topics: Plasmid, lentiviral, aav

Comments